IPO Tracker
Lifecycle-aware IPO monitoring from filing interest through post-listing evidence.
A small, manually selected starter list tracking upcoming, filed, priced, listed, and post-listing names without mixing them into standard AnalystScope coverage before the data quality is ready.
Manual tracker, source-backed where possible
Entries use SEC identifiers, exchange quote pages, and clearly labelled market-reporting context where available. AnalystScope readiness, valuation posture, risks, and promotion judgment remain manual. This is not a live IPO feed, not a recommendation engine, and not personal investment advice.
Automation boundary
The internal checker can inspect known tracked CIKs, review-state flags, and the separate IPO quote artifact. It does not publish new IPO entries, change valuation posture, generate fair values, or promote names into standard coverage.
Tracked entries
5
Small, curated universe only.
SEC-backed entries
5
CIK/entity context on file.
Post-listing tracking
5
Not standard coverage by default.
IPO quote artifact
5/0/0
Fresh / stale / pending, separate from coverage quotes.
Objective review needed
2
Triggered by quote, source, range, or data-quality checks.
Lifecycle buckets
Where each tracked name stands
Quotes and source checks can refresh automatically. Signals and preliminary fair values remain manual/model-reviewed.
Upcoming / filed
0Rumoured names and companies with public filing context.
Priced / listing soon
0Offer terms exist, but public trading evidence is not complete.
Recently listed
3Source-backed listings within the last 12 months.
Older monitored
2Post-listing names outside the first-year window or awaiting date verification.
Lifecycle view
The Tracker separates lifecycle stage from AnalystScope readiness. A listed IPO can still be watch-only if disclosure, quote handling, or normalized statements are not yet strong enough.
Browse filters
Promotion rule
IPO Tracker names do not become standard AnalystScope coverage just because a ticker exists. Promotion requires stable quote handling, enough public reporting, normalized statement support, and defendable model assumptions.
Stable ticker, exchange, public float, and share-count treatment.
Enough SEC filing and reporting history to normalize revenue, margin, cash flow, and dilution.
A defendable bridge from IPO disclosures to durable public-company economics.
Quote handling that can support performance tracking without mixing the name into standard coverage too early.
Tracked IPOs
5 of 5 entries match the current filters. Every row is a manual Tracker artifact, even when SEC or exchange links are attached.
SpaceX
Last reviewed Jun 15, 2026
Latest manual update
Migrated from IPO Watch into IPO Tracker as a post-listing monitoring example. The entry uses SEC/ticker context and manual IPO pricing context, but remains preliminary and manual-review-required.
Automated maintenance state
Auto-checked today
Objective quote, source-check, and lifecycle fields passed automated maintenance. IPO signal and valuation remain manual/model-reviewed.
Automated checks may refresh quotes and source/review metadata only. The IPO signal, confidence, and fair-value range remain manual/model-reviewed.
Source-backed context
SEC entity mapping, exchange quote page, and market reporting are available. Investment posture remains manual and preliminary.
IPO research view
The asset quality and optionality are unusually high, but the public equity case still depends on wide assumptions around Starlink economics, defense/government work, AI-linked infrastructure, capex, governance, and float. AnalystScope is not treating the IPO price or current quote as a standard-coverage buy signal.
Ticker, SEC entity context, exchange quote page, IPO pricing context, and first-close context are available; normalized public-company statements and segment economics are still manual-review items.
Preliminary valuation layer
Wide manual scenario range anchored to IPO pricing context, reported revenue context, and platform/space-infrastructure peer sense-checks; not a full institutional DCF.
Quote artifact updates objective prices only. IPO signals, peer ranges, and valuation interpretation remain manually reviewed and do not promote this ticker into standard coverage.
Fair-value range
$95.00 / $145 / $220
Range is deliberately wide. Current quote may reflect optionality that is not yet supportable with normalized public-company financials.
Base vs offer
+7.4%
Base vs current
-5.4%
Current marker appears only when the separate IPO quote artifact has source-tagged data. Marker positions are clipped to the displayed range to avoid implying precision beyond the manual low/base/high view.
Post-listing performance
Source-tagged IPO Tracker quote is inside the daily freshness window.
Separate IPO quote artifact
Current price is sourced from Yahoo Finance market quote as of Jun 27, 2026, 07:15 AM UTC. This quote does not enter standard AnalystScope coverage or homepage quote gates.
Offer price
$135
Source-backed
First close
$161
Source-backed
Current price
$153
Quote-tracked | Jun 27, 2026, 07:15 AM UTC
Current vs offer
+13.5%
Based on source-tagged IPO Tracker quote data.
Current vs first close
-4.8%
Shown only when first-close and current quote data are both source-backed.
Days since IPO
15
Listing date Jun 12, 2026
What the business is
Launch, satellite-connectivity, defense-adjacent infrastructure, and AI-linked infrastructure platform with economics that span launch cadence, Starlink monetization, government work, and heavy capital deployment.
What matters fundamentally
Segment economics between launch, Starlink, defense/government work, and AI-linked infrastructure, plus capital intensity, share structure, lock-up supply, and whether reported losses narrow into durable cash generation.
Fundamental snapshot
Early IPO fundamentals stay separate from standard AnalystScope normalized statements. Pending fields remain visible as manual tie-out items rather than being filled with placeholder math.
Revenue
Public reporting references 2025 revenue near $18.7 billion; needs SEC filing tie-out before model use.
Growth
Unavailable / pending manual tie-out
Gross margin
Unavailable / pending manual tie-out
Operating margin
Unavailable / pending manual tie-out
Net income / loss
Public reporting references a large 2025 loss; needs SEC filing tie-out before model use.
Cash flow / burn
Unavailable / pending manual tie-out
Cash
Unavailable / pending manual tie-out
Debt
Unavailable / pending manual tie-out
Implied market cap
Approximately $1.77 trillion at offer price, based on public IPO reporting.
EV / Sales
Not shown; EV bridge and share-count treatment need manual tie-out.
EV / Gross profit
Not shown; segment gross-profit disclosure needs manual tie-out.
Profitability
Not yet suitable for standard normalized profitability assumptions.
Use of proceeds
Unavailable / pending manual tie-out
Governance / control
High; supervoting/governance structure and founder control require manual review.
Lock-up / float
High; float, lock-up supply, and secondary liquidity can dominate early trading.
Concentration
Government/defense and Starlink concentration mix requires segment-level review.
Peer group
Peer multiple frame
Scenario range only; peer multiples are too imperfect for a tight read.
Peer comparison read
Current quote should be treated as an optionality-rich premium case until public segment economics are clearer.
Why peers are imperfect
No clean public peer combines launch, satellite connectivity, defense/government work, and AI-linked infrastructure with the same capital intensity and governance profile.
Business quality comparison
Strategic asset quality is high, but investability depends on whether public reporting proves durable cash generation rather than narrative scarcity value.
Filing / disclosure summary
SEC ticker mapping identifies Space Exploration Technologies Corp under SPCX. The Tracker treats the entry as filing-informed and post-listing monitored, not standard company coverage.
Financial disclosure Filing-level disclosure exists, but normalized public-company statements and segment-level durable economics are not yet connected to AnalystScope standard coverage.
What still needs to be seen
A normalized public reporting base, first post-listing earnings cadence, clearer segment profitability, updated capex bridge, and a usable public float/share-count picture before stronger full-coverage modelling would be credible.
Confidence trigger At least one public reporting cycle that connects the prospectus disclosure to actual public-company results, with enough segment and cash-flow detail to build a durable operating base.
Valuation posture
Preliminary valuation
Preliminary IPO Tracker work only. A public ticker and filing-level setup make early valuation framing possible, but AnalystScope is not treating SpaceX as standard coverage until quote handling, normalized statement support, public reporting cadence, and segment economics are model-ready.
Key risks / blockers
IPO trading and limited float can overwhelm the fundamental read-through.
Lock-up supply, supervoting governance, and capital intensity may dominate early pricing.
AI and space optionality can create a wide gap between narrative value and durable cash generation.
Recent trail
CoreWeave
Last reviewed Apr 6, 2026
Latest manual update
Post-listing read remains restrained. Early trading does not yet reduce the uncertainty around cash generation, financing posture, or customer concentration.
Automated maintenance state
Manual valuation review required
Current price is outside the manual 45-75 preliminary range. The retained range was reviewed at $115.21, and the quote has moved -16.2% since that review.
Valuation review needed
Current quote is outside the manual valuation range. This flags owner review only; it does not update the IPO signal, confidence, or valuation range automatically.
Automated checks may refresh quotes and source/review metadata only. The IPO signal, confidence, and fair-value range remain manual/model-reviewed.
Source-backed context
SEC entity mapping and Nasdaq quote context are available. Valuation posture remains preliminary because of financing and concentration sensitivity.
IPO research view
The public setup has real AI-infrastructure demand, but the current quote can already price in a large amount of sustained utilization, customer durability, and financing support. The signal stays expensive/high-risk unless post-listing filings prove durable free cash flow after capex and financing obligations.
SEC entity context, Nasdaq quote page, IPO offer/first-close context, and current IPO quote artifact support market-price tracking; capex, financing, and customer concentration still need manual model review.
Preliminary valuation layer
Manual peer-multiple sense-check using AI infrastructure and cloud-capacity comparables, adjusted downward for capex intensity, financing dependence, and customer concentration.
Quote artifact updates objective prices only. IPO signals, peer ranges, and valuation interpretation remain manually reviewed and do not promote this ticker into standard coverage.
Fair-value range
$45.00 / $60.00 / $75.00
Current quote-linked upside/downside should be read as a preliminary range test, not a full AnalystScope standard-coverage fair value.
Base vs offer
+50.0%
Base vs current
-37.9%
Current marker appears only when the separate IPO quote artifact has source-tagged data. Marker positions are clipped to the displayed range to avoid implying precision beyond the manual low/base/high view.
Post-listing performance
Source-tagged IPO Tracker quote is inside the daily freshness window.
Separate IPO quote artifact
Current price is sourced from Yahoo Finance market quote as of Jun 27, 2026, 07:15 AM UTC. This quote does not enter standard AnalystScope coverage or homepage quote gates.
Offer price
$40.00
Source-backed
First close
$40.00
Source-backed
Current price
$96.58
Quote-tracked | Jun 27, 2026, 07:15 AM UTC
Current vs offer
+141.4%
Based on source-tagged IPO Tracker quote data.
Current vs first close
+141.4%
Shown only when first-close and current quote data are both source-backed.
Days since IPO
456
Listing date Mar 28, 2025
What the business is
AI infrastructure and GPU-cloud platform where revenue growth, utilization, customer concentration, and financing intensity all shape the operating story at once.
What matters fundamentally
Capex discipline, customer concentration, financing posture, and how much current revenue converts into durable free cash flow are the core analytical questions.
Fundamental snapshot
Early IPO fundamentals stay separate from standard AnalystScope normalized statements. Pending fields remain visible as manual tie-out items rather than being filled with placeholder math.
Revenue
Disclosure exists in public filings; normalized annual bridge still requires manual review.
Growth
High-growth profile, but durable demand versus front-loaded capacity spending remains unproven.
Gross margin
Unavailable / pending manual tie-out
Operating margin
Unavailable / pending manual tie-out
Net income / loss
Unavailable / pending manual tie-out
Cash flow / burn
Capex and financing intensity remain the key open cash-flow question.
Cash
Unavailable / pending manual tie-out
Debt
Financing obligations and interest burden require continued tie-out before EV or leverage conclusions.
Implied market cap
Approximately $23 billion fully diluted value reported around pricing.
EV / Sales
Pending; EV bridge and financing obligations need manual tie-out.
EV / Gross profit
Pending; gross-profit bridge needs manual review.
Profitability
Growth is visible, but durable free cash flow and financing support remain open questions.
Use of proceeds
Unavailable / pending manual tie-out
Governance / control
Manual review required.
Lock-up / float
Material; early IPO float and secondary supply can distort price discovery.
Concentration
Material; customer concentration is a central underwriting risk.
Peer group
Peer multiple frame
Manual revenue/gross-profit multiple range; exact peer fit is weak.
Peer comparison read
Current quote appears to trade at a premium to the manually reviewed base range unless filings prove better cash conversion.
Why peers are imperfect
CoreWeave combines GPU capacity growth, customer concentration, and financing/capex intensity in a way that makes standard software or cloud peers too clean.
Business quality comparison
Demand exposure is attractive, but business quality depends on utilization, financing terms, and whether growth converts into free cash flow.
Filing / disclosure summary
SEC ticker mapping and public filings exist for CRWV. The tracker posture remains post-listing monitoring because capex, financing, and customer concentration are central to the model.
Financial disclosure Public filings exist, but normalization needs more confidence around data-center capex, financing obligations, and customer concentration.
What still needs to be seen
More evidence on durable cash generation, capex discipline, and how much of current demand is structural versus front-loaded capacity spending.
Confidence trigger A few public reporting cycles showing that growth, utilization, and cash generation hold together without increasingly aggressive capital support.
Valuation posture
Preliminary valuation
A preliminary valuation range is possible because the company is public, but the range is still wide and highly sensitive to capex, financing, and concentration assumptions.
Key risks / blockers
Heavy capex and financing dependence can distort early valuation signals.
Customer concentration may make revenue quality less durable than headline growth implies.
AI infrastructure demand can be cyclical if capacity additions outrun durable workloads.
Recent trail
Klarna
Last reviewed Apr 4, 2026
Latest manual update
The public setup is clearer than before, but early reporting still leaves too much uncertainty around through-cycle credit and funding durability.
Automated maintenance state
Auto-checked today
Objective quote, source-check, and lifecycle fields passed automated maintenance. IPO signal and valuation remain manual/model-reviewed.
Automated checks may refresh quotes and source/review metadata only. The IPO signal, confidence, and fair-value range remain manual/model-reviewed.
Source-backed context
SEC entity mapping and NYSE quote context are available. The key watch issue is whether public reporting resolves credit and funding durability.
IPO research view
The current quote can be monitored separately, but AnalystScope is not ready to call the stock attractive because credit losses, funding costs, take-rate durability, and through-cycle profitability remain too important and not yet normalized.
SEC entity context, NYSE quote page, IPO offer context, and current IPO quote artifact support monitoring; first-close and through-cycle credit/funding evidence still need manual verification.
Preliminary valuation layer
Valuation pending. A peer range is withheld until credit-cycle profitability, funding costs, and normalized loss assumptions are reviewed.
Quote artifact updates objective prices only. IPO signals, peer ranges, and valuation interpretation remain manually reviewed and do not promote this ticker into standard coverage.
Fair-value range
Pending
A lower current quote versus IPO offer is not enough to create an attractive signal without through-cycle credit and funding evidence.
Base vs offer
Pending
Base vs current
Pending
Valuation pending
AnalystScope is intentionally withholding a fair-value range until the filing, quote, peer, and fundamental evidence is strong enough for a useful preliminary estimate.
Post-listing performance
Source-tagged IPO Tracker quote is inside the daily freshness window.
Separate IPO quote artifact
Current price is sourced from Yahoo Finance market quote as of Jun 27, 2026, 07:15 AM UTC. This quote does not enter standard AnalystScope coverage or homepage quote gates.
Offer price
$40.00
Source-backed
First close
Pending
Pending
Current price
$20.29
Quote-tracked | Jun 27, 2026, 07:15 AM UTC
Current vs offer
-49.3%
Based on source-tagged IPO Tracker quote data.
Current vs first close
Pending
Shown only when first-close and current quote data are both source-backed.
Days since IPO
290
Listing date Sep 10, 2025
What the business is
Consumer-payments and BNPL platform where growth, funding mix, credit outcomes, and transaction economics all feed into the durable earnings picture.
What matters fundamentally
Credit loss behavior, funding durability, take-rate quality, and whether newer growth vectors can translate into through-cycle profitability are the key valuation drivers.
Fundamental snapshot
Early IPO fundamentals stay separate from standard AnalystScope normalized statements. Pending fields remain visible as manual tie-out items rather than being filled with placeholder math.
Revenue
Disclosure exists in public filings; through-cycle comparability still needs manual review.
Growth
Unavailable / pending manual tie-out
Gross margin
Unavailable / pending manual tie-out
Operating margin
Unavailable / pending manual tie-out
Net income / loss
Unavailable / pending manual tie-out
Cash flow / burn
Unavailable / pending manual tie-out
Cash
Unavailable / pending manual tie-out
Debt
Funding mix and credit-related obligations need manual review.
Implied market cap
Approximately $17 billion reported around first trading.
EV / Sales
Pending; EV and funding bridge need manual tie-out.
EV / Gross profit
Pending; gross-profit economics need manual review.
Profitability
Public reporting exists, but credit-cycle profitability is not yet a high-confidence base case.
Use of proceeds
Unavailable / pending manual tie-out
Governance / control
Manual review required.
Lock-up / float
Material; IPO float and lock-up supply may affect early price discovery.
Concentration
Credit/funding sensitivity matters more than single-customer concentration for this entry.
Peer group
Peer multiple frame
Withheld until loss, funding, and margin assumptions are normalized.
Peer comparison read
Discount to the IPO offer may reflect risk repricing rather than a clear bargain.
Why peers are imperfect
Payments peers understate credit risk, while consumer-credit peers may overstate balance-sheet intensity; BNPL economics need a through-cycle view.
Business quality comparison
The platform has scale and brand visibility, but business quality depends on credit losses, funding durability, and repeatable take-rate economics.
Filing / disclosure summary
SEC ticker mapping and public filings exist for KLAR. AnalystScope still needs through-cycle credit, funding, and margin evidence before stronger conviction.
Financial disclosure Public filings exist, but the durable base case depends on credit loss behavior, funding mix, and newer product economics.
What still needs to be seen
A cleaner through-cycle view on credit performance, funding durability, margin structure, and how fast newer growth vectors translate into durable earnings power.
Confidence trigger More public quarters showing that credit, funding, and margin performance stay credible outside a favorable initial listing window.
Valuation posture
Preliminary valuation
A market quote exists, but any fair-value language should stay preliminary because through-cycle credit and funding assumptions still dominate the outcome.
Key risks / blockers
Consumer-credit sensitivity can make early growth look stronger than through-cycle economics.
Funding costs and credit losses can reprice the business quickly.
Product expansion may blur the durable take-rate and margin profile.
Recent trail
Hinge Health
Last reviewed Apr 7, 2026
Latest manual update
Readiness improved after a cleaner early read on growth and margin profile, but retention and employer durability still need more proof.
Automated maintenance state
Manual valuation review required
Current price is outside the manual 38-65 preliminary range. The retained range was reviewed at $67.04, and the quote has moved 17.8% since that review.
Valuation review needed
Current quote is outside the manual valuation range. This flags owner review only; it does not update the IPO signal, confidence, or valuation range automatically.
Automated checks may refresh quotes and source/review metadata only. The IPO signal, confidence, and fair-value range remain manual/model-reviewed.
Source-backed context
SEC entity mapping and NYSE quote context are available. Readiness depends on retention, employer adoption, and margin durability.
IPO research view
The business profile is more legible than many digital-health IPOs and could become model-ready, but the current quote still needs to be tested against retention, employer economics, and margin durability before AnalystScope would use a stronger positive signal.
SEC entity context, NYSE quote page, IPO offer context, and current IPO quote artifact support market monitoring; first-close and multiple reporting periods still need manual review.
Preliminary valuation layer
Manual peer-multiple range using software-enabled care, digital-health, and employer-benefit platform comparables, discounted for limited public reporting history.
Quote artifact updates objective prices only. IPO signals, peer ranges, and valuation interpretation remain manually reviewed and do not promote this ticker into standard coverage.
Fair-value range
$38.00 / $50.00 / $65.00
A quote above the high end of this preliminary range does not automatically mean sell; it means the stock needs more retention and margin proof before stronger conviction.
Base vs offer
+56.3%
Base vs current
-36.7%
Current marker appears only when the separate IPO quote artifact has source-tagged data. Marker positions are clipped to the displayed range to avoid implying precision beyond the manual low/base/high view.
Post-listing performance
Source-tagged IPO Tracker quote is inside the daily freshness window.
Separate IPO quote artifact
Current price is sourced from Yahoo Finance market quote as of Jun 27, 2026, 07:15 AM UTC. This quote does not enter standard AnalystScope coverage or homepage quote gates.
Offer price
$32.00
Source-backed
First close
Pending
Pending
Current price
$78.97
Quote-tracked | Jun 27, 2026, 07:15 AM UTC
Current vs offer
+146.8%
Based on source-tagged IPO Tracker quote data.
Current vs first close
Pending
Shown only when first-close and current quote data are both source-backed.
Days since IPO
401
Listing date May 22, 2025
What the business is
Software-enabled musculoskeletal-care platform combining digital engagement, provider delivery, and employer-backed health spend.
What matters fundamentally
Retention, employer economics, contribution margin durability, and how much current profitability depends on unusually favorable mix or timing are the core fundamentals to test.
Fundamental snapshot
Early IPO fundamentals stay separate from standard AnalystScope normalized statements. Pending fields remain visible as manual tie-out items rather than being filled with placeholder math.
Revenue
Disclosure exists in public filings; growth quality requires continued reporting review.
Growth
Visible but still needs durability proof across more public periods.
Gross margin
Unavailable / pending manual tie-out
Operating margin
Unavailable / pending manual tie-out
Net income / loss
Unavailable / pending manual tie-out
Cash flow / burn
Unavailable / pending manual tie-out
Cash
Unavailable / pending manual tie-out
Debt
Unavailable / pending manual tie-out
Implied market cap
Pending; current quote and share-count bridge require manual tie-out.
EV / Sales
Pending; EV bridge and revenue base need manual tie-out.
EV / Gross profit
Pending; gross-profit disclosure needs manual review.
Profitability
Early profitability evidence is promising but not yet durable enough for full coverage.
Use of proceeds
Unavailable / pending manual tie-out
Governance / control
Manual review required.
Lock-up / float
Material; early IPO float and lock-up supply may affect price discovery.
Concentration
Employer/channel concentration and retention require ongoing review.
Peer group
Peer multiple frame
Manual revenue/margin multiple range; broad because profitability durability is not settled.
Peer comparison read
Current quote needs to be compared against a wide range rather than a single target because margin durability remains unproven.
Why peers are imperfect
Pure software peers overstate scalability, while healthcare-services peers may understate software-enabled margin potential.
Business quality comparison
Higher-quality than many digital-health watch names if retention and employer ROI hold, but evidence is still short of full coverage.
Filing / disclosure summary
SEC ticker mapping and public filings exist for HNGE. The entry is closer to model readiness, but still needs more reporting history before standard coverage.
Financial disclosure Public filings exist and the operating story is more legible than many digital-health listings, but retention and employer economics still need more proof.
What still needs to be seen
More public evidence on retention, employer economics, margin durability, and whether early profitability holds up without depending on one unusually favorable period.
Confidence trigger More proof that retention, employer adoption, and margin improvement hold across multiple reporting periods, not just the first public read.
Valuation posture
Model-ready soon
Early fair-value work is becoming plausible, but it still belongs in a restrained range-building posture rather than a full published rating.
Key risks / blockers
Employer demand, retention, and engagement durability still need public-market proof.
Digital-health margin improvement can reverse if service intensity rises.
Reimbursement and buyer-budget sensitivity can change quickly.
Recent trail
StubHub
Last reviewed Apr 3, 2026
Latest manual update
Still monitored as a credible marketplace case, but event-cycle volatility keeps the base-case bridge too noisy for standard coverage.
Automated maintenance state
Auto-checked today
Objective quote, source-check, and lifecycle fields passed automated maintenance. IPO signal and valuation remain manual/model-reviewed.
Automated checks may refresh quotes and source/review metadata only. The IPO signal, confidence, and fair-value range remain manual/model-reviewed.
Source-backed context
SEC entity mapping and NYSE quote context are available. The right posture is post-listing monitoring, not a standard fair-value call.
IPO research view
The post-listing price action may look optically cheaper than the IPO offer, but the model still lacks a clean cycle-adjusted bridge for take rate, event mix, working-capital timing, and durable margin structure. AnalystScope is not ready to call the decline an attractive setup.
SEC entity context, NYSE quote page, IPO pricing context, manual first-close snapshot, and current IPO quote artifact support monitoring; cycle-adjusted fundamentals still need manual review.
Preliminary valuation layer
Valuation pending. A peer range is withheld until gross ticket activity, take rate, event-cycle volatility, and cash-flow conversion are normalized.
Quote artifact updates objective prices only. IPO signals, peer ranges, and valuation interpretation remain manually reviewed and do not promote this ticker into standard coverage.
Fair-value range
Pending
A lower current quote versus IPO offer may reflect fundamental uncertainty rather than an investable discount.
Base vs offer
Pending
Base vs current
Pending
Valuation pending
AnalystScope is intentionally withholding a fair-value range until the filing, quote, peer, and fundamental evidence is strong enough for a useful preliminary estimate.
Post-listing performance
Source-tagged IPO Tracker quote is inside the daily freshness window.
Separate IPO quote artifact
Current price is sourced from Yahoo Finance market quote as of Jun 27, 2026, 07:15 AM UTC. This quote does not enter standard AnalystScope coverage or homepage quote gates.
Offer price
$23.50
Source-backed
First close
$22.17
Source-backed
Current price
$12.40
Quote-tracked | Jun 27, 2026, 07:15 AM UTC
Current vs offer
-47.2%
Based on source-tagged IPO Tracker quote data.
Current vs first close
-44.1%
Shown only when first-close and current quote data are both source-backed.
Days since IPO
283
Listing date Sep 17, 2025
What the business is
Secondary-ticketing marketplace with economics driven by transaction volume, take-rate discipline, event mix, and marketing intensity.
What matters fundamentally
Cycle-adjusted demand, take-rate durability, margin stability, and the cash-flow bridge through working-capital timing are the main questions.
Fundamental snapshot
Early IPO fundamentals stay separate from standard AnalystScope normalized statements. Pending fields remain visible as manual tie-out items rather than being filled with placeholder math.
Revenue
Disclosure exists in public filings; event-cycle comparability needs manual review.
Growth
Pending cycle-adjusted review.
Gross margin
Unavailable / pending manual tie-out
Operating margin
Unavailable / pending manual tie-out
Net income / loss
Unavailable / pending manual tie-out
Cash flow / burn
Working-capital timing may make cash generation noisy.
Cash
Unavailable / pending manual tie-out
Debt
Unavailable / pending manual tie-out
Implied market cap
Approximately $8 billion to $9 billion reported around pricing/first close.
EV / Sales
Pending; EV and gross ticket activity bridge need manual tie-out.
EV / Gross profit
Pending; gross-profit/take-rate bridge needs manual review.
Profitability
Profitability is not yet a high-confidence durable base case.
Use of proceeds
Unavailable / pending manual tie-out
Governance / control
Manual review required.
Lock-up / float
Material; early IPO float and secondary supply can pressure price discovery.
Concentration
Less a single-customer issue; event mix and marketplace liquidity matter more.
Peer group
Peer multiple frame
Withheld until cycle-adjusted marketplace economics are clearer.
Peer comparison read
Current discount to IPO offer is not enough for a positive signal without normalized marketplace economics.
Why peers are imperfect
Marketplace peers vary by take rate, inventory risk, event cyclicality, and working-capital profile.
Business quality comparison
Marketplace liquidity can be valuable, but event-cycle volatility and take-rate pressure make business quality harder to underwrite early.
Filing / disclosure summary
SEC ticker mapping and public filings exist for STUB. The entry remains watch-only because event cyclicality and marketplace economics need a cleaner durable bridge.
Financial disclosure Public filings exist, but gross ticket activity, take rate, cyclicality, and working-capital timing still need normalization.
What still needs to be seen
A better bridge from reported revenue and event activity into durable margin structure, cash generation, and how cyclical volume should be treated in the base case.
Confidence trigger A cleaner bridge from gross ticket activity to durable cash generation, plus better evidence on how event-cycle volatility distorts reported periods.
Valuation posture
Watch only
Watch, not rate. Public visibility is improving, but durable range confidence is still too soft for standard fair-value language.
Key risks / blockers
Event-cycle volatility can distort growth and margin signals.
Take-rate pressure and competition can compress marketplace economics.
Working-capital timing may make near-term cash generation noisy.
Recent trail
What the internal checker can do
The protected IPO checker is designed to inspect known tracked CIKs for SEC filing changes, compare them against the local Tracker metadata, and report which entries need manual review. It is intentionally a review assistant, not a publishing workflow.
Report newer SEC filing metadata when available.
Flag stale manual reviews and entries with manual-review-required.
Surface listed tickers that still lack quote-tracking readiness.
Avoid changing valuation posture, fair value, or standard coverage status.
What this page is not
IPO Tracker is not a live IPO calendar, not a scraped news feed, and not a shortcut into standard AnalystScope coverage. A listed ticker can be tracked here for months while AnalystScope waits for cleaner reporting, normalized statement support, and defensible valuation assumptions.
Route compatibility remains /ipo-watch, but the product label and mental model are now IPO Tracker.